AI assistant
Sending…
SRx Health Solutions, Inc. — Director's Dealing 2021
Aug 23, 2021
35114_dirs_2021-08-23_14c8afc1-56e5-466d-bbb3-29b4f195d6ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Better Choice Co Inc. (BTTR)
CIK: 0001471727
Period of Report: 2021-08-19
Reporting Person: Lerner Scott (CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-20 | Common Stock | P | 1445 | $3.50 | Acquired | 12746 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-19 | Stock Options - Right to Buy | $5.0 | A | 25000 | Acquired | 2031-08-19 | Common Stock (25000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2667 | Indirect |
| Common Stock | 20 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options - Right to Buy | $5.0 | 2031-07-08 | Common Stock (33333.0) | 33333 | Direct |
| Purchase Warrants - Right to Buy | $7.5 | 2027-01-22 | Common Stock (4000.0) | 4000 | Direct |
| Purchase Warrants - Right to Buy | $7.5 | 2027-01-22 | Common Stock (2667.0) | 2667 | Indirect |
| Stock Options - Right to Buy | $8.82 | 2031-03-03 | Common Stock (200000.0) | 200000 | Direct |
| Stock Options - Right to Buy | $6.78 | 2030-12-28 | Common Stock (83334.0) | 83334 | Direct |
Footnotes
F1: Options granted on August 19, 2021 and 67% of the options shall vest as to 1/3rd of the shares on the first annual anniversary of the grant date and 1/36th of the shares to vest on each monthly anniversary thereafter, and 33% of the options shall vest as to 1/3rd of the shares on the 18 month anniversary of the grant date and 1/36th of the shares to vest on each monthly anniversary thereafter.
F2: Options exercisable according to the vesting terms in the related option agreement.
More from SRx Health Solutions, Inc.
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 17
Merger & Acquisition
2026
Apr 14
Capital/Financing Update
2026
Mar 18
Capital/Financing Update
2026
Mar 3
Delisting Announcement
2026
Feb 20
Capital/Financing Update
2026
Feb 13
Capital/Financing Update
2026
Feb 13
Interim / Quarterly Report
2026
Feb 13
Major Shareholding Notification
2026
Feb 12